REQUEST A DEMO
Total
USD $0.00
Search more companies

Act Pharma Sp. z o.o. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical Preparation Manufacturing | All Other Specialty Food Stores | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Lessors of Real Estate | Administrative Management and General Management Consulting Services | Advertising Agencies
Full name: Act Pharma Sp. z o.o. Profile Updated: June 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Act Pharma Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. It operates in the Department Stores industry. It was established on January 03, 2017. The company’s latest financial report indicates a net sales revenue increase of 15.24% in 2022. Its’ total assets recorded a growth of 55.84%. The net profit margin of Act Pharma Sp. z o.o. increased by 0.7% in 2022.

Headquarters
Ul. Wilenska 14/1C
Warsaw; Mazowieckie; Postal Code: 03-414

Contact Details: Purchase the Act Pharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Act Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Act Pharma Sp. z o.o. report to view the information.
Incorporation Date:
January 03, 2017
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
95%
Company Performance
Financial values in the chart are available after Act Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
15.24%
Total operating revenue
14.41%
Operating profit (EBIT)
42.08%
EBITDA
43.18%
Net Profit (Loss) for the Period
37.1%
Total assets
55.84%
Total equity
56.78%
Operating Profit Margin (ROS)
0.92%
Net Profit Margin
0.7%
Return on Equity (ROE)
-5.2%
Quick Ratio
0.46%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?